SOPHiA GENETICS SA

SOPHiA GENETICS SA (SOPH) priced its initial public offering on Jul 23, 2021 at $18.00 per share, within its $17.00–$19.00 range, raising $234M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.14B. Davis Polk advised the company and Cooley advised the underwriters.

SOPHiA GENETICS SA is a healthcare technology company with a cloud-based software-as-a-service platform, begun in 2011, that analyzes complex multimodal health data to support diagnosis, therapy selection and drug development. Customers pay per analysis performed on the platform.

Status

IPO

Ticker

SOPH

Exchange

Nasdaq Global Select

Priced

Jul 23, 2021

IPO price

$18.00

Price range

$17.00–$19.00

Raised

$234M

Market cap at IPO price

$1.14B

First filed

Jul 2, 2021

Company counsel

Davis Polk

Underwriters' counsel

Cooley

Sector

Technology

Country / state

Switzerland

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.